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Background: The clinical impact of sirolimus-eluting stent (SES) on the long-term prognosis of hemodialysis patients in “real world” is unclear. We 
evaluated clinical outcomes of hemodialysis patients after coronary interventions in SES era.
Methods: We investigated all hemodialysis patients who underwent coronary interventions after launching of SESs whose follow-up periods were 
more than 3-years.
Results: Follow-up contacts were available in 87 (97.8%) hemodialysis patients. Median follow-up period was 42.4months. SESs were implanted 
in 71.3% and bare metal stents were in 8.0%. All cause mortality, cardiac death, myocardial infarction, cerebrovascular event and TLR rates were 
47.1%, 21.8%, 3.4%, 4.6% and 27.6%. The TLR rate after SES implantation was lower than other procedures (19.4% vs.42.9%, p=0.03); however, all 
cause mortalities were similar between SES implanted patients and other procedure patients (Figure).
Conclusions: SESs were implanted in many hemodialysis patients in “real world”, and it could reduce the TLR rate after coronary 
interventions. However, it might not improve the long-term survival rate, and long-term prognosis of hemodialysis patients was still poor. 
